Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that c...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2016-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/7949 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849729850017841152 |
|---|---|
| author | Nina A. Petunina Anna L. Terekhova Ekaterina V. Goncharova |
| author_facet | Nina A. Petunina Anna L. Terekhova Ekaterina V. Goncharova |
| author_sort | Nina A. Petunina |
| collection | DOAJ |
| description | The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that canagliflozin, which provides significant weight loss ability, improves the quality of life and satisfaction with physical and emotional health in patients with diabetes compared with sitagliptin. |
| format | Article |
| id | doaj-art-fb4b48718f144cf18d9defcf7341b996 |
| institution | DOAJ |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2016-12-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-fb4b48718f144cf18d9defcf7341b9962025-08-20T03:09:04ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782016-12-0119651151710.14341/DM79497574Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitorNina A. Petunina0Anna L. Terekhova1Ekaterina V. Goncharova2Sechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversityThe article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that canagliflozin, which provides significant weight loss ability, improves the quality of life and satisfaction with physical and emotional health in patients with diabetes compared with sitagliptin.https://www.dia-endojournals.ru/jour/article/view/7949sglt-2 inhibitorscanagliflozinsitagliptinhealth related quality of life (hrqol)impact of weight on quality of life-lite (iwqol-lite)current health satisfaction questionnaire (ches-q) |
| spellingShingle | Nina A. Petunina Anna L. Terekhova Ekaterina V. Goncharova Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor Сахарный диабет sglt-2 inhibitors canagliflozin sitagliptin health related quality of life (hrqol) impact of weight on quality of life-lite (iwqol-lite) current health satisfaction questionnaire (ches-q) |
| title | Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor |
| title_full | Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor |
| title_fullStr | Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor |
| title_full_unstemmed | Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor |
| title_short | Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor |
| title_sort | comparative analysis of quality of life in patients treated with canagliflozine or dpp iv inhibitor |
| topic | sglt-2 inhibitors canagliflozin sitagliptin health related quality of life (hrqol) impact of weight on quality of life-lite (iwqol-lite) current health satisfaction questionnaire (ches-q) |
| url | https://www.dia-endojournals.ru/jour/article/view/7949 |
| work_keys_str_mv | AT ninaapetunina comparativeanalysisofqualityoflifeinpatientstreatedwithcanagliflozineordppivinhibitor AT annalterekhova comparativeanalysisofqualityoflifeinpatientstreatedwithcanagliflozineordppivinhibitor AT ekaterinavgoncharova comparativeanalysisofqualityoflifeinpatientstreatedwithcanagliflozineordppivinhibitor |